| Literature DB >> 26681943 |
Mona Guidoum1, Hind Kherfi-Kadi2, Ouahiba Benharkat-Boughaba3, Aicha Djemaa-Bendjazia4, Sihem Keghouche5, Behnoush Abedi-Ardekani6, Amina Azzouz1, Yacine Kadi2, Pierre Hainaut7, Zihad Bouslama1.
Abstract
The aim of this study is to compare histological patterns and to estimate the burden of thyroid cancers in the two Wilayahs (departments) of El-Taref and Guelma in northeast of Algeria (total population 0.9 million), locally reputed as having different rates of endemic thyroid diseases and cancer. A retrospective analysis of central pathology registers and clinical records of patients with thyroid diseases, covering the period 2008-2012, was conducted. A total of 145 cases of thyroid cancers with histological confirmation were registered in the two Wilayahs during the period, with a female to male ratio of 5.9 : 1. Estimates of crude incidence rates suggested that thyroid cancers were twice as frequent in the Wilayah of Guelma compared to El-Taref (p < 0.05) with a tendency to occur at a younger age in resident of the Wilayah of El-Taref. Diagnoses of thyroid adenoma were more frequent in the Wilayah of Guelma, whereas the prevalence of other thyroid lesions, including goitre, was similar in the two Wilayahs. This first descriptive study on geographic variations in thyroid cancer in Northern Africa suggests that significant differences may occur in relation with environmental and lifestyle exposures.Entities:
Year: 2015 PMID: 26681943 PMCID: PMC4670666 DOI: 10.1155/2015/849416
Source DB: PubMed Journal: J Cancer Epidemiol ISSN: 1687-8558
Figure 1Localisation of data sources. The original data on thyroid lesions used in the study were extracted from the registries of the Departments of Pathology of District Hospitals in Guelma and El-Taref (Eastern Algeria), as well as from clinical records from a tertiary referral treatment center in the nearby city of Constantine. Data on cancer incidence from two population-based cancer registries in Algiers and Sétif were used for comparison.
Histopathological definition of cases.
| District of Guelma | District of El-Taref | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Men | Women | M/F ratio | Men | Women | M/F ratio | |||||
| Number | % | Number | % | Number | % | Number | % | |||
| All lesions | 42 | 8.33 | 256 | 50.79 | 1 : 6.1 | 15 | 2.98 | 191 | 37.9 | 1 : 12.7 |
|
| ||||||||||
| Hyperplasia | 11 | 2.18 | 74 | 14.68 | 1 : 6.7 | 10 | 1.98 | 149 | 29.56 | 1 : 14.9 |
| Thyroiditis | ||||||||||
| Hashimoto's | 0 | 0.00 | 2 | 0.4 | — | 0 | 0.00 | 4 | 0.79 | — |
| Lymphocytic | 0 | 0.00 | 11 | 2.18 | — | 0 | 0.00 | 2 | 0.4 | — |
| Other | 4 | 0.79 | 2 | 0.4 | 1 : 0.5 | 0 | 0.00 | 6 | 1.19 | — |
|
| ||||||||||
| Follicular adenoma | 11 | 2.18 | 58 | 11.51 | 1 : 5.3 | 0 | 0.00 | 8 | 1.59 | — |
| Hyalinizing trabecular tumors | 0 | 0.00 | 7 | 1.39 | — | 0 | 0.00 | 0 | 0.00 | — |
| Papillary carcinoma | 9 | 1.78 | 85 | 16.86 | 1 : 9.4 | 5 | 0.99 | 14 | 2.78 | 1 : 2.8 |
| Follicular carcinoma | 6 | 1.19 | 15 | 2.98 | 1 : 2.5 | 0 | 0.00 | 7 | 1.39 | — |
| Medullary carcinoma | 0 | 0.00 | 1 | 0.20 | — | 0 | 0.00 | 1 | 0.2 | — |
| Anaplastic carcinoma | 1 | 0.20 | 1 | 0.20 | 1 : 1 | 0 | 0.00 | 0 | 0.00 | — |
Figure 2Distribution of different forms of neoplastic lesions of the thyroid in men and women in the districts of Guelma and of El-Taref. A.C: anaplastic carcinoma, M.C: medullary carcinoma, F.C: follicular carcinoma, P.C: papillary carcinoma, H.T.T: hyalinizing trabecular tumors, V.A: follicular adenoma.
Estimates of crude incidence rates of cancers of the thyroid in different Wilayahs of Algeria.
| Wilayahs(a) | Period | Crude rates, per 100,000 person-years | Data source | |
|---|---|---|---|---|
| Men | Women | |||
| Guelma | 2008–2012 | 3.31 | 21.14 | Hospital-based data, this study |
|
| ||||
| El-Taref | 2008–2012 | 1.2 | 5.39 | Hospital-based data, this study |
|
| ||||
| Algiers | 1993–1997 | 0.9 | 3.5 | CIV-8(b) |
| 2003 | 1.7 | 7.7 | Population-based cancer registry(c) | |
| 2006 | 1.2 | 8 | ||
| 2007 | 1.8 | 6.3 | ||
|
| ||||
| Setif | 1986–1989 | 0.2 | 0.8 | CIV-6 [ |
| 1990–1993 | 0.1 | 0.4 | CIV-7 [ | |
| 1998–2002 | 0.9 | 2.6 | CIV-9(d) | |
| 2006 | 0.8 | 4.0 | Population-based cancer registry(d) | |
| 2010 | 1.5 | 6.0 | Population-based cancer registry(d) | |
|
| ||||
| Annaba | 2003–2009 | 1 | 3.1 | Population-based cancer registry(e) |
(a): see Figure 1 for localization of data sources.
(b): cancer incidence in five Continents, IARC, (http://ci5.iarc.fr/) [15].
(c): Registres des Tumeurs d'Algers, 2003, 2006, and 2007 [16–18].
(d): cancer registry of Setif; for age-standardized incidence rates (world standard) see [19].
(e): Rapport du Registre des Cancers d'Annaba, 2003–2009, unpublished (personal communication, Dr Bouzbid).